Impetigo Antibiotic Stewardship and the Need for Treatment Alternatives

Impetigo Antibiotic Stewardship and the Need for Treatment Alternatives

Impetigo is a highly contagious bacterial skin infection that primarily affects the skin’s surface. It is most commonly caused by Staphylococcus aureus and, less frequently, Streptococcus pyogenes. Although the condition is generally self-limiting, treatment is recommended to reduce symptoms, limit transmission and prevent potential complications.

Topical antibiotics have traditionally played an important role in managing localised, uncomplicated impetigo. However, increasing antimicrobial resistance to commonly used topical antibiotics has become a growing concern in dermatology.

A review published in the Journal of Drugs in Dermatology examines the importance of antibiotic stewardship in impetigo management and highlights the need for alternative topical treatment options to address emerging resistance challenges.

1. Understanding Impetigo and Its Management

Impetigo is a bacterial skin infection that spreads easily through direct contact. The two primary bacterial organisms associated with the condition are:

  • Staphylococcus aureus
  • Streptococcus pyogenes

Although impetigo is typically self-limiting, appropriate treatment plays an important role in reducing symptom burden, limiting the spread of infection and preventing complications.

For localised, uncomplicated cases, topical antibiotics remain the first-line treatment approach. Their use helps manage the infection while addressing the need for targeted treatment.

However, the effectiveness of commonly used antibiotics is increasingly challenged by antimicrobial resistance.

2. Growing Concerns About Topical Antibiotic Resistance

Antimicrobial resistance is an important challenge in the management of bacterial skin infections.

The review highlights widely reported resistance to several topical antibiotics commonly used for impetigo, including:

  • Mupirocin: A commonly used topical antibiotic for bacterial skin infections.
  • Fusidic acid: Another topical antibiotic used in the treatment of impetigo.
  • Retapamulin: A topical antibiotic used for managing localised bacterial skin infections.

The increasing prevalence of resistance to these agents highlights the need to reconsider antibiotic use and explore alternative treatment strategies.

When bacteria develop resistance, commonly used treatments may become less effective, creating challenges for infection management.

This makes responsible antibiotic selection and appropriate treatment duration particularly important.

3. Antibiotic Stewardship: An Essential Part of Impetigo Management

Antibiotic stewardship refers to the responsible and appropriate use of antibiotics to optimise treatment while limiting the development and spread of antimicrobial resistance.

In impetigo management, stewardship focuses on ensuring that the right antibiotic is used for the right duration.

The review emphasises several important considerations:

Appropriate antibiotic selection

Selecting an appropriate antibiotic is essential for effective infection management. Treatment decisions should consider local trends in antimicrobial resistance.

Right treatment duration

Using antibiotics for the appropriate duration is an important component of stewardship. Unnecessary or inappropriate antibiotic exposure should be avoided.

Awareness of resistance patterns

Understanding resistance to commonly prescribed topical antibiotics can help inform treatment decisions and support more effective management strategies.

These principles are essential for preserving the effectiveness of existing antimicrobial treatments.

4. Ozenoxacin: An Alternative Topical Treatment Approach

The review highlights topical ozenoxacin as a potential option for addressing some of the limitations associated with existing topical antibiotics.

Ozenoxacin is a topical antibiotic with activity against organisms resistant to other topical agents. It also has a low capacity for developing resistance.

These characteristics make it an important treatment alternative in the context of growing antimicrobial resistance.

The review suggests that ozenoxacin may help address existing treatment gaps while supporting antibiotic stewardship-informed care.

Its role highlights the importance of developing newer topical antimicrobial agents that can contribute to effective infection management while considering resistance concerns.

5. The Need for New Treatment Alternatives

Increasing resistance to commonly used topical antibiotics demonstrates the need for continued research and development of alternative treatments.

The review emphasises the importance of exploring new topical antibiotics alongside strategies that promote responsible antimicrobial use.

Treatment alternatives should be evaluated not only for their clinical efficacy and safety but also for their potential to contribute to antimicrobial resistance.

In addition, incorporating local antimicrobial resistance trends into treatment decisions can help address the limitations of existing approaches.

A combination of appropriate antibiotic selection, stewardship principles and newer therapeutic options may help optimise impetigo management.

The Future of Impetigo Management

Antimicrobial resistance presents an important challenge in dermatology, particularly in the management of common bacterial skin infections such as impetigo.

Although topical antibiotics remain the first-line treatment for localised, uncomplicated impetigo, increasing resistance to mupirocin, fusidic acid and retapamulin highlights the need for alternative therapeutic approaches.

Topical ozenoxacin represents one such option, with its activity against resistant organisms and low capacity for resistance development offering potential advantages.

The integration of antibiotic stewardship principles, awareness of local resistance patterns and development of newer topical agents will be important in shaping future impetigo management.

Conclusion

Effective impetigo management requires more than selecting an antibiotic. It also involves responsible prescribing practices and consideration of antimicrobial resistance.

The growing resistance to commonly used topical antibiotics reinforces the importance of antibiotic stewardship and the need for alternative treatment options.

As research and clinical understanding continue to evolve, newer topical agents such as ozenoxacin may contribute to addressing existing treatment gaps and supporting more effective, stewardship-informed dermatological care.

Reference:

Schachner L, Andriessen A, Benjamin L, Gonzalez ME, Hebert A, Kircik L, Kwong P, Lio P, Pinera-Llano A, Torrelo A, Adzovic V, Silverberg N. (2026). Impetigo Antibiotic Stewardship and the Need for Treatment Alternatives. Journal of Drugs in Dermatology. 25(11):1003–1009. DOI: https://doi.org/10.36849/JDD.10182